Clonazepam has long been identified as among the finest-founded treatment plans for very long-term neurological and psychiatric care because of its precision system of action, lengthy 50 percent-daily life and confirmed clinical reliability. Its capability to selectively bind to GABA-A receptors and stabilize hyperactive neural pathways makes it a